Bloomberg: Arthur Hayes has recently made a significant investment in a human longevity extension company and has been receiving regular intravenous stem cell infusion therapy over the past year.
BlockBeats News, August 21st. According to Bloomberg, BitMEX co-founder Arthur Hayes is shifting his investment focus to the field of human life extension. He recently made a significant investment in a stem cell company with clinics in Mexico and Bangkok, and has joined its board of directors. Over the past year, he has regularly flown to receive intravenous infusion treatments, stating that he "hopes to extend his life as healthily as possible." While the company's name was not disclosed due to ongoing rebranding, he emphasized: "This is a future trend - an increasing number of countries are relaxing regulations on stem cell usage."
You may also like
Gainers
Latest Crypto News
Suspected Ethena Labs Withdraws Another 25 Million ENA
Yesterday's Whale Trader Who Perfectly Shorted Before the Major Drop Goes Long on ETH with 2x Leverage, Holding a Position Worth $56 Million
Tom Lee: S&P 500 to Rise to 7300, Surge in Market Liquidity Could Be Explosive
Franklin Templeton XRP Spot ETF AUM Surpasses $100 Million
「ZEC&MON Top Short in History」 Take-Profit Section: The ZEC short position has made a profit of over $5 million, while simultaneously shorting MON has a unrealized gain of nearly $2 million.
Customer Support:@weikecs
Business Cooperation:@weikecs
Quant Trading & MM:bd@weex.com
VIP Services:support@weex.com